ArticleCureus2025
Biomarkers of Oxidative Stress and Inflammation in Chronic Kidney Disease: A Cross-Sectional Study of Vitamin C and Pentraxin 3 Dynamics During Hemodialysis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioinformatic analysis identifies LPL as a critical gene in diabetic kidney disease via lipoprotein metabolism.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic kidney disease (CKD) is a condition where there is a progressive decline in kidney function, which is characterized by an estimated glomerular filtration rate of less than 60 mL/min/1.73 m². Vitamin C is a strong antioxidant, and pentraxin 3 (PTX3) is an early reliable sign of vascular inflammation and cardiovascular risk. However, it is still not clear how these two markers interact with each other during hemodialysis. This study aimed to correlate vitamin C and pentraxin-3 levels pre- and post-dialysis among CKD patients.
methodsA prospective observational study was conducted at Dhanalakshmi Srinivasan Medical College and Hospital, involving 60 CKD patients aged more than 18 years who were on maintenance hemodialysis. After obtaining written informed consent, we collected the participants' demographic information, clinical data, and biochemical parameters from their medical records. We used high-performance liquid chromatography (HPLC) and enzyme-linked immunosorbent assay (ELISA) to check the levels of vitamin C and PTX3 in the blood sample taken 30 minutes before and after dialysis. Vitamin C levels were classified as deficient, low, or normal, and pentraxin 3 values were categorized as normal, mildly elevated, moderately elevated, and severely elevated. A paired t-test was used to assess pre- and post-dialysis variations among the blood biochemical parameters. Pearson's correlation analysis was done to determine the correlation between vitamin C and pentraxin 3 in hemodialysis patients.
resultsThe study population had a mean age of 52.88 ± 9.55 years, with 51 (85%) males. Vitamin C levels dropped significantly after dialysis from 0.24 ± 0.092 mg/dL to 0.19 ± 0.085 mg/dL (p = 0.001), but PTX3 levels increased from 4.64 ± 1.299 ng/mL to 6.63 ± 1.259 ng/mL (p = 0.001) after dialysis. A total of 40 (66.67%) study participants were found to have low vitamin C levels; vitamin C deficiency was present in 19 (31.67%) participants in a pre-dialysis state, and their condition worsened further post-dialysis. A total of 31 (51.67%) participants had severely elevated PTX 3 levels, which further increased post-dialysis. PTX3 levels were consistently higher in hypertensive and diabetic patients, highlighting the inflammatory burden in these populations. There exists a weak, nonsignificant negative correlation between vitamin C and PTX 3 levels both pre- (r = -0.137, p = 0.781) and post-dialysis (r = -0.141, p
conclusionAlthough this observational study cannot establish causality, it indicates that hemodialysis is associated with reduced antioxidant levels and increased inflammatory markers. These findings suggest a possible link between oxidative stress and inflammation in CKD patients. Further studies are needed to evaluate the therapeutic role of antioxidant supplementation in mitigating cardiovascular risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.